InvestorsHub Logo
icon url

md1225

06/04/13 6:24 AM

#125905 RE: keep_trying #125898

GREAT POST KT "KING AND COMPANY" PLEASE READ!
icon url

volgoat

06/04/13 6:41 AM

#125909 RE: keep_trying #125898

I keep in mind that it is doctors who prescribe treatment for patients, not Pharma that want to ace out competition. Ultimately, doctors know that they have the prescribing authority and will do right by their patients. Venues like ASCO help doctors find their way to best treatment options and ASCO doctors saw Bavi results.

They take kickbacks from BP to prescribe drugs and recommend trials.
IF PPHM "tries"to go alone, BP's will push patients to BP trials. Yes, 5 years or more to enroll 600 patients..1 screw up and could be longer than 5 years. One drug that comes along with promising results and BP's steer them to that trial even if Bavi is better and safer. PPHM can start a PHIII, but will never finish one..That is why Cotara is sitting on a shelf right now...If it were so easy, they would have started that trial already.

If it was easy, every Biotech would be doing it..
icon url

asmarterwookie

06/04/13 7:58 AM

#125925 RE: keep_trying #125898

Top O' the Mornin Peregrowing KM Curve Tails!!! GREAT Posts KT and as always thanks FTM and the rest of this awesome board!!

One thought about recruiting patients that always crosses my mind is the "Going Viral" effect of the internet.

If PPHM could get data published in say The New England Journal or other HIGHLY reputable publication HIGHLIGHTING Bavituximab as a Real Prospect to stop cancer. Who's to say the "build it and they will come" effect would not take place?

Cancer sufferers are always looking for what they can do to save themselves from what I've heard. In the "Google Age", a patient can simply search "Treatments for Lung Cancer" and with enough Web Presence, Bavituximab will be on top.

My point? We are in a new age of medicine, technology and communication. I believe the old ways are good but the new ways are leaner meaner and much more efficient.

Another thought is Cotara. Fastrack in USA and Orphan Status in USA and EU. How much for that PIII with Fast Track to commercialization?
Not only for income BUT for the notoriety that PPHM so desperately needs.


imho

Best of Data, FDA Approval(s), Partner(s), Imaging, Production and Research!!

wook
icon url

entdoc

06/04/13 10:09 AM

#125957 RE: keep_trying #125898

KT,I like your post on PPHM going it alone. For years I have said that is a viable option if/when product is clearly better than competition, or fulfills an obvious need. No "sales" force is necessary. You were mostly right about doctors being in the driver's seat, but some huge caveats apply. Number one concern is family and self. We all want to keep our license to "practice" another day...to feed/clothe ourselves, etc., and therefore avoid being out in front of the crowd. We are bound by a legal concept, the "standard of care" which is a bit fuzzy, but the implication is clear. Can I prove that a prudent professional would administer this treatment choice vs. another more time-tested one? Oncologists are in the hotseat for malpractice suits, almost as much as radiologists and obstetricians, because a relatively higher percentage of their patients die, and they are dealing with remote and often greedy family members, and not the patient they have established a relationship with. So in the rare instance the patient is daring and the doctor is willing, what about the bereft family. Using standard of care, whether effective or not, is often preferable to trying a new approach with more promise.